The key question: Will Indias GLP-1 market be driven by affordabilityor by trust and clinical confidence
In July, the European Medicines Agency (EMA) expanded its investigation of Ozempics manufacturer Novo Nordisk, after "150 reports of possible cases of self-injury and suicidal thoughts." However, Novo Nordisk said in a statement, The totality of available evidence which includes clinical studies and data from real world-use does not suggest an increased risk of suicide or self-injurious behavior with Ozempic
However, direct studies specifically evaluating Ipamorelin's effects on sleep quality metrics are limited
- - - In a study of 460,000+ adults on GLP-1s (mostly with T2D): 13% developed nutritional deficiencies in 6 months 22% within 12 months Vitamin D deficiency was most common (13.6%) 3% experienced muscle loss Patients who saw a dietitian were more likely to have deficiencies identifiednot because dietitians caused harm, but because they actually looked
-25% NOW KSM-66 Ashwagandha 600 mg / 90 Vcaps 30.75 / 60.14
Includes bilberry extract known for its beneficial properties